Equitable access to biomedical advances: getting beyond the rights impasse.
D000028:Abortion, Induced; D000163:Acquired Immunodeficiency Syndrome; D020811:Biomedical Technology; D002961:Civil Rights; D003362:Cost-Benefit Analysis; D003695:Delivery of Health Care; D004345:Drug Industry; D015507:Drugs, Investigational; D035082:Federal Government; D005380:Financing, Government; D005602:France; D006076:Government; D033161:Government Regulation; D015276:Health Care Rationing; D006801:Humans; D007603:Jurisprudence; D015735:Mifepristone; D016377:Organ Transplantation; D010344:Patient Advocacy; D005791:Patient Care; D010361:Patients; D004364:Pharmaceutical Preparations; D011057:Politics; D017149:Private Sector; D011640:Public Policy; D017150:Public Sector; D040841:Resource Allocation; D012926:Social Control, Formal; D012935:Social Justice; D012941:Social Responsibility; D014481:United States; D014486:United States Food and Drug Administration
Health Care and Public Health; Legal Approach; Roussel Uclaf